✦ LIBER ✦

Sefety of retreatment with antisense to icam-1 (isis 2302) in patients with steroid-dependent Crohn's disease

✍ Scribed by Yacyshyn, B.R.; Bowen-Yacyshyn, M.B.; Tami, J.; Sahba, B.; Shanahan, W.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, placebo-controlled trial o

✍ Yacyshyn, Bruce R.; Chey, W.Y.; Goff, J; Salzberg, B; Baerg, R; Buchman, A.L.; T 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 341 KB

Double-blinded, randomized, placebo-cont

✍ Yacyshyn, Bruce R.; Chey, W.; Goff, J.; Salzberg, B.; Buchman, A.; Baerg, R.; An 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Gene polymorphisms and serological marke

✍ B. R. Yacyshyn; A. Schievella; K. L. Sewell; J. A. Tami 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

Budesonide is superior to mesalazine in

✍ G.J. Mantzaris; K. Petraki; E. Chadio; E. Archavlis; A. Christidou; G. Triantafy 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Safety of switching systemic steroids to

✍ Cortot, Antoine; Colombel, Jean-Frederic; Rutgeerts, Paul; Lauritsen, Karsten; M 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Effect of switching to budesonide on the

✍ Cortot, Antoine; Colombel, Jean-Frederic; Rutgeerts, Paul; Lauritsen, Karsten; M 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 174 KB